Veterinary Medicines

LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Spectinomycin sulfate
  • Lincomycin hydrochloride
Download as PDF

Product identification

Medicine name:
LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Spectinomycin sulfate
  • Lincomycin hydrochloride
Target species:
  • Sheep
  • Goat
  • Cattle (calf)
  • Pig
  • Chicken
  • Turkey
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Spectinomycin sulfate
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Goat
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Cattle (calf)
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Pig
      • Meat and offal
        14
        day
    • Chicken
      • Meat and offal
        14
        day
    • Turkey
      • Meat and offal
        14
        day
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 56768/16-06-2021/K-0015804
Date of authorisation status change: